drugset / Trial / NCT03139565
High Dose vs. Standard Influenza Vaccine in Adult SOT
RandomizedParallel-groupTriple-blindPrevention
Summary
The study will test whether a high dose influenza vaccination results in improved immunogenicity in adult SOT recipients as compared to standard vaccine. This will be a single center prospective observer-blind randomized controlled trial conducted at the Toronto General Hospital Multi-Organ Transplant Unit, University Health Network, Toronto, Ontario, Canada.
Timeline
- Start
- 2016-10
- Primary completion
- 2017-06
- Completion
- 2020-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluzone High-dose Influenza Vaccine | Vaccine | 60 ug | Intramuscular |
| Comparator | Standard 2016-2017 Flu vaccine | Vaccine | 15 ug | Intramuscular |
| Comparator | Standard 2016-2017 Flu vaccine | Vaccine | 0.5 ml | Intramuscular |